1-4 of 4
transplantation, autologous
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evidence-Based Minireview: What is the optimal timing of anti–PD-1 antibodies in relapsed classical Hodgkin lymphoma?

Pamela Blair Allen, Ann S. LaCasce
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 249–251.
https://doi.org/10.1182/hematology.2019000077
Published: 2019
Journal Articles

Roundtable: How I treat a newly diagnosed patient with high-risk myeloma

Jonathan L. Kaufman
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 120–124.
https://doi.org/10.1182/hematology.2019000015
Published: 2019
Journal Articles

Advances in Biology and Therapy of Multiple Myeloma

Sophie Barillé-Nion, Bart Barlogie, Régis Bataille, P. Leif Bergsagel, Joshua Epstein, Robert G. Fenton, Joth Jacobson, W. Michael Kuehl, John Shaughnessy, Guido Tricot
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2003) 2003 (1): 248–278.
https://doi.org/10.1182/asheducation-2003.1.248
Published: 2003
Journal Articles

Non-Myeloablative Transplantation

David G. Maloney, Brenda M. Sandmaier, Stephen Mackinnon, Judith A. Shizuru
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2002) 2002 (1): 392–421.
https://doi.org/10.1182/asheducation-2002.1.392
Published: 2002